Literature DB >> 29286406

High-throughput Parallel Sequencing to Measure Fitness of Leptospira interrogans Transposon Insertion Mutants During Golden Syrian Hamster Infection.

Kristel Lourdault1, James Matsunaga2, Karen V Evangelista2, David A Haake3.   

Abstract

In this manuscript, we describe a transposon sequencing (Tn-Seq) technique to identify and quantify Leptospira interrogans mutants altered in fitness during infection of Golden Syrian hamsters. Tn-Seq combines random transposon mutagenesis with the power of high-throughput sequencing technology. Animals are challenged with a pool of transposon mutants (input pool), followed by harvesting of blood and tissues a few days later to identify and quantify the number of mutants in each organ (output pools). The output pools are compared to the input pool to evaluate the in vivo fitness of each mutant. This approach enables screening of a large pool of mutants in a limited number of animals. With minor modifications, this protocol can be performed with any animal model of leptospirosis, reservoir host models such as rats and acute infection models such as hamsters, as well as in vitro studies. Tn-Seq provides a powerful tool to screen for mutants with in vivo and in vitro fitness defects.

Entities:  

Mesh:

Year:  2017        PMID: 29286406      PMCID: PMC5755599          DOI: 10.3791/56442

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  38 in total

1.  Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis.

Authors:  Julio Croda; Claudio Pereira Figueira; Elsio A Wunder; Cleiton S Santos; Mitermayer G Reis; Albert I Ko; Mathieu Picardeau
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

Review 2.  Pathogenesis of leptospirosis: the influence of genomics.

Authors:  Ben Adler; Miranda Lo; Torsten Seemann; Gerald L Murray
Journal:  Vet Microbiol       Date:  2011-03-05       Impact factor: 3.293

3.  A new family of mobilizable suicide plasmids based on broad host range R388 plasmid (IncW) and RP4 plasmid (IncPalpha) conjugative machineries and their cognate Escherichia coli host strains.

Authors:  Gaëlle Demarre; Anne-Marie Guérout; Chiho Matsumoto-Mashimo; Dean A Rowe-Magnus; Philippe Marlière; Didier Mazel
Journal:  Res Microbiol       Date:  2005-03       Impact factor: 3.992

4.  Hamster model of leptospirosis.

Authors:  David A Haake
Journal:  Curr Protoc Microbiol       Date:  2006-09

Review 5.  Transposon insertion sequencing: a new tool for systems-level analysis of microorganisms.

Authors:  Tim van Opijnen; Andrew Camilli
Journal:  Nat Rev Microbiol       Date:  2013-05-28       Impact factor: 60.633

6.  Selection-driven gene loss in bacteria.

Authors:  Sanna Koskiniemi; Song Sun; Otto G Berg; Dan I Andersson
Journal:  PLoS Genet       Date:  2012-06-28       Impact factor: 5.917

7.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences.

Authors:  Jeremy Goecks; Anton Nekrutenko; James Taylor
Journal:  Genome Biol       Date:  2010-08-25       Impact factor: 13.583

8.  Genome-scale identification of resistance functions in Pseudomonas aeruginosa using Tn-seq.

Authors:  Larry A Gallagher; Jay Shendure; Colin Manoil
Journal:  mBio       Date:  2011-01-18       Impact factor: 7.867

9.  Kinetics of Leptospira interrogans infection in hamsters after intradermal and subcutaneous challenge.

Authors:  Mariana L Coutinho; James Matsunaga; Long-Chieh Wang; Alejandro de la Peña Moctezuma; Michael S Lewis; Jane T Babbitt; Jose Antonio G Aleixo; David A Haake
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

10.  The OmpA-like protein Loa22 is essential for leptospiral virulence.

Authors:  Paula Ristow; Pascale Bourhy; Flávia Weykamp da Cruz McBride; Claudio Pereira Figueira; Michel Huerre; Patrick Ave; Isabelle Saint Girons; Albert I Ko; Mathieu Picardeau
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.